Abstract:In an effort to better understand skin development, Han et al. created transgenic mice in which the expression of the inhibitory Smad, Smad7, can be induced in keratinocytes and epidermal stem cells. Smad7 was chosen because its expression is increased in pathological skin conditions. An inducible system was required to allow more precise control of the concentration of Smad7 and because constitutive expression of Smad 7 in keratinocytes of transgenic mice is embryonic lethal. Expression of Smad7 during embryogenesis disrupted hair follicle morphogenesis and differentiation. Expression in adults also inhibited hair follicle growth, promoted sebaceous gland growth, and caused epidermal hyperplasia. At concentrations that produced the effects noted, Smad7 (in the inducible system or in a low expressing constitutive transgenic mouse) did not inhibit transforming growth factor-β (TGF-β) signaling (detected as phosphorylated Smad2) or bone morphogenetic protein (BMP) signaling (detected as phosphorylated Smad 1, 5, and 8) and did not inhibit the expression of some Smad target genes. Thus, Smad7 at the concentrations that caused phenotypic changes was not completely effective in blocking Smad signaling. Wnt and hedgehog signaling are also involved in hair follicle and sebaceous gland development. In skin, increased expression of Smad7 caused a decrease in the abundance of β-catenin, a key component of the Wnt signaling pathway, without altering β-catenin transcription. In Smad7 mice crossed with mice expressing a Wnt reporter gene, less reporter gene expression was visible in the mice in which Smad7 expression was increased. Both acute and prolonged expression of Smad7 decreased the abundance of β-catenin. The authors used cultured cells to show that Smad7 promoted the proteasomal-mediated degradation of β-catenin. Cotransfection experiments suggested that Smad7 recruited the E3 ubiquitin ligase Smurf to β-catenin to mediate ubiquitination of β-catenin. A comparison of aged wild-type skin and skin from 7-month-old Smad7-overexpressing mice showed similar phenotypic skin changes and similar expression levels of the Smad7 transcript. Skin from aged mice also showed a reduction in β-catenin abundance compared with skin from wild-type young mice. All of these results suggest that in skin, at physiological concentrations, Smad7 is a regulator of Wnt signaling rather than TGF-β signaling (see Millar for discussion). G. Han, A. G. Li, Y.-Y. Liang, P. Owens, W. He, S. Lu, Y. Yoshimatsu, D. Wang, P. Ten Dijke, X. Lin, X.-J. Wang, Smad7-induced β-catenin degradation alters epidermal appendage development. Dev. Cell 11 , 301-312 (2006). [PubMed] S. E. Millar, Smad7: Licensed to kill β-catenin. Dev. Cell 11 , 274-276 (2006). [PubMed]

SMAD7 Enhances Adult Β-Cell Proliferation Without Significantly Affecting Β-Cell Function in Mice

Β-Cell Smad2 Null Mice Have Improved Β-Cell Function and Are Protected from Diet-Induced Hyperglycemia

SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity

Smad7 Enables STAT3 Activation and Promotes Pluripotency Independent of TGF-β Signaling

The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential

Smad3 deficiency promotes beta cell proliferation and function in db/db mice via restoring Pax6 expression

Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues.

Smad3 deficiency improves islet-based therapy for diabetes and diabetic kidney injury by promoting β cell proliferation via the E2F3-dependent mechanism

In Vivo Disruption Of Tgf-Beta Signaling By Smad7 Leads To Premalignant Ductal Lesions In The Pancreas

Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes

The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo

microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2

Disruption of Smad7 Promotes ANG II-Mediated Renal Inflammation and Fibrosis Via Sp1-TGF-β/Smad3-NF.κB-Dependent Mechanisms in Mice

Overexpression of Smad7 in Hypothalamic POMC Neurons Disrupts Glucose Balance by Attenuating Central Insulin Signaling.

Smad7 Protects Against Acute Kidney Injury by Rescuing Tubular Epithelial Cells from the G1 Cell Cycle Arrest.

Protection of Cerulein-Induced Pancreatic Fibrosis by Pancreas-Specific Expression of Smad7.

Smad4 Deficiency Substitutes Cdkn2b but Not Cdkn2a Downregulation in Pancreatic Cancer Following Induction of Genetic Events in Adult Mice

Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated β Cell Aging in Pancreas-specific SMAD7 Mutant Mice

Smad7 Prevents Activation of Hepatic Stellate Cells and Liver Fibrosis in Rats.

203-OR: VGLL4 and MENIN Function As TEAD1 Corepressors to Block Pancreatic SS-Cell Proliferation

Smad7 Inhibits Wnt Signaling